New Drug May Stop Melanoma
According to a study published in EBioMedicine, a drug that is already undergoing clinical trials may work differently than expected and may be an effective treatment for several types of cancer—including this aggressive type of skin cancer. Each year in the U.S., 80,000 people are diagnosed with melanoma and about 10,000 die of the disease. This new study suggests a drug called pevonedistat may stop cancer from spreading.
The drug appears to shut down proteins that allow cancer cells to replicate quickly. Without these proteins, including a specific marker called CDT2, cancer cells are not able to replicate and die.
Pevonedistat is still being tested. It is not yet known if the drug is safe and effective. According to researchers, it shows promise in treating melanoma that is resistant to current therapies. If eventually approved, it could become an effective second-line melanoma treatment.
Image Credit: Thinkstock